clinicaltrialsarena4h
Longboard Pharmaceuticals begins Phase III Dravet syndrome trial
Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...
clinicaltrialsarena13h
ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
clinicaltrialsarena1h
AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.
clinicaltrialsarena22h
Moderna blamed after children offered £1,500 to take part in Covid-19 trial
An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III ...